Together the inherent transcriptional and metabolic adaptations to reduced Pcyt2 expression and activity cause a progressive metabolic dysfunction, culminating in obesity, insulin resistance, and hypertriglyceridemia21,37. Here, PCYT2 is linked to obesity disorder.